Convert AbbVie (Ondo Tokenized) ABBVON to o1.exchange O
ABBVON to O: 1 AbbVie (Ondo Tokenized) converts to 565.76 O
Earn up to $2,000 when you buy $50 in crypto
Earn free crypto after making your first purchase. Terms apply.
Sum of median estimated savings and rewards earned, per user in 2021 across multiple Coinbase programs (excluding sweepstakes). This amount includes fee waivers from Coinbase One (excluding the subscription cost), rewards from Coinbase Card, and staking rewards.
About ABBVON and O
AbbVie (Ondo Tokenized) is falling, while o1.exchange is climbing this week. The current ABBVON to O conversion rate is 565.76. Inversely, this means that if you convert 1 O you will get 0.001768 ABBVON. The conversion rate of ABBVON/O has increased by 2.21% in the last hour (O/ABBVON decreased by 2.17%). In the last 24 hours, ABBVON/O shrunk by 12.79%, while O/ABBVON grew by 14.66%.
The exchange rate of AbbVie (Ondo Tokenized) is increasing. The current value of 1 ABBVON is 565.76 O. In other words, to buy 5 AbbVie (Ondo Tokenized), it would cost you 2,828.81 O. Inversely, 1 O would allow you to trade for 0.001768 ABBVON while 50 O would convert to 0.08838 ABBVON, not including platform or gas fees.
In the last 7 days, the exchange rate has increased by 0%. Meanwhile, in the last 24 hours, the rate has changed by 0%, which means that the highest exchange rate of 1 ABBVON to O was 0.00 O and the lowest 24 hour value was 1 ABBVON for ∞ O. Last month, 1 ABBVON was worth 0.00 O. Today, it's up 0%. Looking back a year, AbbVie (Ondo Tokenized) has changed by NaN O. That means that in a single year, the value of AbbVie (Ondo Tokenized) has grown by 0%.
AbbVie (Ondo Tokenized) Market Stats
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.
o1.exchange Market Stats
$O is the native token of the o1.exchange platform, which focuses on enabling efficient and secure digital asset exchange. The platform's documentation provides details on its operational framework and token utility.
Conversion tables
ABBVON to O values from Today at 6:42 pm
0.5 ABBVON = 282.88 O |
1 ABBVON = 565.76 O |
5 ABBVON = 2,828.81 O |
10 ABBVON = 5,657.63 O |
50 ABBVON = 28,288.13 O |
100 ABBVON = 56,576.27 O |
500 ABBVON = 282,881.34 O |
1,000 ABBVON = 565,762.67 O |
O to ABBVON values from Today at 6:04 am
0.5 O = 0.0008838 ABBVON |
1 O = 0.001768 ABBVON |
5 O = 0.008838 ABBVON |
10 O = 0.01768 ABBVON |
50 O = 0.08838 ABBVON |
100 O = 0.1768 ABBVON |
500 O = 0.8838 ABBVON |
1,000 O = 1.77 ABBVON |
ABBVON to O over time
ABBVON | Today | 24H 100.00% | 1M 100.00% | 1Y 100.00% |
|---|---|---|---|---|
0.5 ABBVON | 282.88 O | 0.00 O | 0.00 O | 0.00 O |
1 ABBVON | 565.76 O | 0.00 O | 0.00 O | 0.00 O |
5 ABBVON | 2,828.81 O | 0.00 O | 0.00 O | 0.00 O |
10 ABBVON | 5,657.63 O | 0.00 O | 0.00 O | 0.00 O |
50 ABBVON | 28,288.13 O | 0.00 O | 0.00 O | 0.00 O |
100 ABBVON | 56,576.27 O | 0.00 O | 0.00 O | 0.00 O |
500 ABBVON | 282,881.34 O | 0.00 O | 0.00 O | 0.00 O |
1,000 ABBVON | 565,762.67 O | 0.00 O | 0.00 O | 0.00 O |
Frequently asked questions
Buy AbbVie (Ondo Tokenized) with Coinbase
Create a Coinbase account to buy and sell AbbVie (Ondo Tokenized) on the most secure crypto exchange.
Related conversions
Learn how to buy popular cryptocurrencies
Popular prediction markets
Discover other cryptocurrencies to currency conversions
Discover other cryptocurrency conversions
Start your crypto portfolio today
Sign up for a Coinbase account today and see what the world of decentralized finance can do for you.
This content is being provided to you for informational purposes only, does not constitute an offer, or solicitation of an offer nor a recommendation by Coinbase to buy, sell, or hold any security, financial product, or instrument referenced in the content, and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Data presented may reflect asset prices traded on the Coinbase exchange as well as other cryptocurrency exchanges and market data platform. Coinbase may charge fees for the processing of cryptocurrency transactions which may not be reflected in the conversion prices displayed. Coinbase is not liable for any errors or delays in content, or for any actions taken in reliance on any content.


